Electromedical Technologies, Inc.
EMED · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 8.9% | -50.8% | -19.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -104.1% | -102.1% | -15.8% | -24.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,833.8% | -1,474.1% | -1,750.7% | -1,543.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$0 | $0 |
| % Margin | -8,340.1% | -1,507.2% | -2,010.7% | 210.3% |
| EPS | 0 | 0 | -0 | 0.001 |
| % Growth | – | 100% | -140% | – |
| EPS Diluted | 0 | 0 | -0 | 0.001 |
| Weighted Avg Shares Out | 4,951 | 2,890 | 1,429 | 945 |
| Weighted Avg Shares Out Dil | 4,951 | 2,890 | 1,429 | 945 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -4,617.2% | -1,280.7% | -1,660.6% | 604.1% |